Abacavir lamivudine contraindications

Abacavir lamivudine
EPZICOM ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

EPZICOM Tablets are contraindicated in patients with:

• previously demonstrated hypersensitivity to abacavir or to any other component of the product. NEVER restart EPZICOM or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B
• 5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].*hepatic impairment [see Use in Specific Populations (8.7)].

References

Adapted from the FDA Package Insert.